Literature DB >> 18707193

Risk factors associated with adverse drug reactions following hospital admission: a prospective analysis of 907 patients in two German university hospitals.

Yurdaguel Zopf1, Christina Rabe, Antje Neubert, Eckhart G Hahn, Harald Dormann.   

Abstract

BACKGROUND: Since the 1970s, studies have examined potential risk factors associated with adverse drug reactions (ADRs) in a variety of settings. However, no pharmacoepidemiological study exists that incorporates clinical and laboratory parameters in a multiple regression model in order to consider predictors for ADRs.
OBJECTIVES: To characterize risk factors associated with ADRs in patients admitted to university hospital departments of internal medicine. DESIGN AND
SETTING: Intensive pharmacovigilance was carried out in departments of internal medicine of two university hospitals. All admissions were followed prospectively for the occurrence of ADRs by members of a pharmacoepidemiological team consisting of physicians, pharmacologists and pharmacists. To identify patients at high risk for experiencing ADRs, patient histories and several clinical and laboratory data, determined at the time of admission, were taken into consideration. In addition to the drug prescribed, 40 parameters defined vital status at admission. These included temperature, heart rate, blood pressure (systolic-diastolic), body mass index, nicotine and alcohol use, and first laboratory test results after admission on nutrition status, inflammation, liver, kidney, pancreas or thyroid status, electrolytes, blood count and coagulation.
RESULTS: 907 patients were observed during the study period. The mean age of the study population was 60 +/- 16 years. The median number of different drugs administered per patient during hospitalization was 9.6 +/- 7.7. In 345 patients, 592 ADRs were evaluated: 33.4% possible, 61.5% probable and 4.7% highly probable. Two ADR-related deaths were observed during the study period. Analysing ADR predictors, 17 of 40 parameters reached significance in univariate analysis, but only five in a multivariate binary regression model: raised temperature (odds ratio [OR] 1.609; 95% CI 1.133, 2.285), low erythrocyte levels (OR 0.386; 95% CI 0.194, 0.768), low thrombocyte levels (OR 0.788, 95% CI 0.627, 0.989), high number of drugs (OR 1.117; 95% CI 1.076, 1.159) and female sex (OR 1.562; 95% CI 0.785, 2.013) were independent predictors for ADRs.
CONCLUSION: For the patients investigated, of the large number of clinical data available only five independent factors predict ADR occurrence. Taking these results into account, physicians will be able to focus early on patients at risk for ADRs. To minimize ADR occurrence, ADR predictors should be integrated into the clinical pathway.

Entities:  

Mesh:

Year:  2008        PMID: 18707193     DOI: 10.2165/00002018-200831090-00007

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


  57 in total

Review 1.  The management of adverse drug reactions: from diagnosis to signal.

Authors:  I R Edwards
Journal:  Therapie       Date:  2001 Nov-Dec       Impact factor: 2.070

2.  Readmissions and adverse drug reactions in internal medicine: the economic impact.

Authors:  H Dormann; A Neubert; M Criegee-Rieck; T Egger; M Radespiel-Tröger; T Azaz-Livshits; M Levy; K Brune; E G Hahn
Journal:  J Intern Med       Date:  2004-06       Impact factor: 8.989

Review 3.  Is gender a risk factor for adverse drug reactions? The example of drug-induced long QT syndrome.

Authors:  M D Drici; N Clément
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

4.  Socio-demographic factors related to the prevalence of adverse drug reaction at hospital admission in an elderly population.

Authors:  Francisco Caamaño; Claudio Pedone; Guiseppe Zuccalà; Pierugo Carbonin
Journal:  Arch Gerontol Geriatr       Date:  2005 Jan-Feb       Impact factor: 3.250

Review 5.  Old age--is it a risk for adverse drug reactions?

Authors:  J H Gurwitz; J Avorn
Journal:  Agents Actions Suppl       Date:  1990

6.  Sex-related variations in the frequency and characteristics of adverse drug reactions.

Authors:  C Domecq; C A Naranjo; I Ruiz; U Busto
Journal:  Int J Clin Pharmacol Ther Toxicol       Date:  1980

7.  Evaluation of the extent of under-reporting of serious adverse drug reactions: the case of toxic epidermal necrolysis.

Authors:  Nicole Mittmann; Sandra R Knowles; Manuel Gomez; Joel S Fish; Robert Cartotto; Neil H Shear
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

8.  Therapeutic risk-assessment model for identifying patients with adverse drug reactions.

Authors:  W Tschepik; R Segal; T P Sherrin; D N Schneider; R L Hammond
Journal:  Am J Hosp Pharm       Date:  1990-02

9.  [Significance of age, sex, kidney function, atopy and number of prescriptions for the occurrence of adverse drug reactions, studied by multivariate statistical methods. Results from the Comprehensive Hospital Drug Monitoring Berne (CHDMB)].

Authors:  R Hoigné; J Sollberger; M Zoppi; U Müller; T Hess; D Fritschy; F Stocker; R Maibach
Journal:  Schweiz Med Wochenschr       Date:  1984-12-08

10.  The application of an institutional clinical data warehouse to the assessment of adverse drug reactions (ADRs). Evaluation of aminoglycoside and cephalosporin associated nephrotoxicity.

Authors:  Q Zhang; Y Matsumura; T Teratani; S Yoshimoto; T Mineno; K Nakagawa; M Nagahama; S Kuwata; H Takeda
Journal:  Methods Inf Med       Date:  2007       Impact factor: 2.176

View more
  36 in total

1.  Risk factors associated with adverse drug reactions in hospitalised children: international multicentre study.

Authors:  Asia N Rashed; Ian C K Wong; Noel Cranswick; Stephen Tomlin; Wolfgang Rascher; Antje Neubert
Journal:  Eur J Clin Pharmacol       Date:  2011-12-14       Impact factor: 2.953

2.  Adverse drug reactions in a population of hospitalized very elderly patients.

Authors:  Balamurugan Tangiisuran; J Graham Davies; Juliet E Wright; Chakravarthi Rajkumar
Journal:  Drugs Aging       Date:  2012-08-01       Impact factor: 3.923

3.  Adverse drug reactions in internal medicine units and associated risk factors.

Authors:  Juan Francisco Sánchez Muñoz-Torrero; Paloma Barquilla; Raul Velasco; Maria del Carmen Fernández Capitan; Nazaret Pacheco; Lucia Vicente; Jose Luis Chicón; Sara Trejo; Jose Zamorano; Alicia Lorenzo Hernandez
Journal:  Eur J Clin Pharmacol       Date:  2010-08-06       Impact factor: 2.953

Review 4.  Underprescription of beneficial medicines in older people: causes, consequences and prevention.

Authors:  Antonio Cherubini; Andrea Corsonello; Fabrizia Lattanzio
Journal:  Drugs Aging       Date:  2012-06-01       Impact factor: 3.923

5.  Adverse Drug Reactions (ADR) and Emergencies.

Authors:  A Marlen Schurig; Miriam Böhme; Katja S Just; Catharina Scholl; Harald Dormann; Bettina Plank-Kiegele; Thomas Seufferlein; Ingo Gräff; Matthias Schwab; Julia C Stingl
Journal:  Dtsch Arztebl Int       Date:  2018-04-13       Impact factor: 5.594

Review 6.  Geriatric conditions and the risk of adverse drug reactions in older adults: a review.

Authors:  Fabrizia Lattanzio; Francesco Landi; Silvia Bustacchini; Angela Marie Abbatecola; Francesco Corica; Luigi Pranno; Andrea Corsonello
Journal:  Drug Saf       Date:  2012-01       Impact factor: 5.606

7.  Mortality among patients due to adverse drug reactions that occur following hospitalisation: a meta-analysis.

Authors:  Parvati B Patel; Tejas K Patel
Journal:  Eur J Clin Pharmacol       Date:  2019-06-11       Impact factor: 2.953

Review 8.  Categorization and association analysis of risk factors for adverse drug events.

Authors:  Lina Zhou; Anamika Paul Rupa
Journal:  Eur J Clin Pharmacol       Date:  2017-12-08       Impact factor: 2.953

Review 9.  Adverse-Drug-Reaction-Related Hospitalisations in Developed and Developing Countries: A Review of Prevalence and Contributing Factors.

Authors:  Mulugeta Tarekegn Angamo; Leanne Chalmers; Colin M Curtain; Luke R E Bereznicki
Journal:  Drug Saf       Date:  2016-09       Impact factor: 5.606

Review 10.  Prevalence of drug interactions in hospital healthcare.

Authors:  María Espinosa-Bosch; Bernardo Santos-Ramos; María Victoria Gil-Navarro; María Dolores Santos-Rubio; Roberto Marín-Gil; Paloma Villacorta-Linaza
Journal:  Int J Clin Pharm       Date:  2012-09-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.